PRF Technologies (PRFX) Return on Capital Employed (2021 - 2024)
PRF Technologies (PRFX) recorded quarterly Return on Capital Employed of 2729.86% in Q2 2024, down 19.82% on a QoQ basis from 3404.55% in Q1 2024, and up 285100.0% year-over-year from N/an in Q3 2023.
PRF Technologies (PRFX) Return on Capital Employed (2021 - 2024) Analysis & Trends
PRF Technologies has disclosed Return on Capital Employed across 4 years of filings, most recently posting 2729.86% for Q2 2024.
- Quarterly Return on Capital Employed rose 285100.0% year-over-year to 2729.86% in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 2729.86% (up 285100.0% YoY) and the FY2025 annual result came in at 88.0%, up 9773200.0% from the prior year.
- Return on Capital Employed eased to 2729.86% in Q2 2024, from 3404.55% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 3404.55% in Q1 2024 and troughed at 192.72% in Q4 2023.
- A 4-year average of 378.4% and a median of 40.97% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 12192 bps — and 2024, when it jumped 349979 bps.
- Tracing PRFX's Return on Capital Employed over 4 years: stood at 38.04% in 2021, then tumbled by 86 bps to 70.8% in 2022, then tumbled by 172 bps to 192.72% in 2023, then jumped by 1516 bps to 2729.86% in 2024.
- Business Quant data shows PRFX's Return on Capital Employed at 2729.86% in Q2 2024, 3404.55% in Q1 2024, and 192.72% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2,729.86% |
| Mar 31, 2024 | 3,404.55% |
| Dec 31, 2023 | -192.72% |
| Sep 30, 2023 | -109.05% |
| Jun 30, 2023 | -121.14% |
| Mar 31, 2023 | -95.25% |
| Dec 31, 2022 | -70.80% |
| Sep 30, 2022 | -51.69% |
| Jun 30, 2022 | -43.11% |
| Mar 31, 2022 | -38.82% |
| Dec 31, 2021 | -38.04% |
| Sep 30, 2021 | -31.64% |
| Jun 30, 2021 | -25.47% |
| Mar 31, 2021 | -19.00% |